Eurofarma Innovation and Growth Strategy
4
50 YEARS OF HISTORY
to Become a Leading Pharmaceutical Company
1972
founded
Billi Pharmaceutical
Foundation
1977
First mover in outsourcing
for other pharma (Carlo Erba Lab)
2001
Entrance into
generic
market
2002
Beginning of exports
1979
Acquisition of the 1st
production unit in
Brazil
1982
Acquisition of the 1st
1987
Acquisition of
Majer Meyer's
Brazilian laboratory to
produce penicillin
brands
1992
Acquisition of Stanley Home
do Brasil
Brazil Expansion:
1993
Eurofarma brand
created
1997
Acquisition of
Pearson
1995
Startup of facilities
of Freguesia do Ó
and Euroglass
1998
Wyeth's brand
acquisition
2006
Foundation of
Innovation Business
Unit, Instituto
Eurofarma and Magabi
2007
Inauguration of the
Itapevi complex
eurofarma
2011
Supera Farma JV
created with Cristália
2014
Stake acquired in Melinta
Therapeutics and
partnerships with Dong-A
2012
Start of Colombia operation
and Orygen Biotech
(partnership with Biolab)
2015
Registration of the 1st
biosimilar medicine in
LatAm
2019
#1 Prescription in Brazil
Neuron Ventures
Acquisition of Medipharm
in Chile and Buxton in
Argentina
Lactare, the first private
milk bank owned by a
pharma company in Brazil
Next Stage of Growth
2020
Eurolab oppening
Acquisition of Takeda and Lilly's
portfolio in the 2nd largest pharma
market in Latam (Mexico)
2009
Acquisition of
Quesada and
Eurofarma
Argentina
foundation;
International
Expansion
2010
Acquisition of Gautier
(Uruguay and Bolivia),
Volta and
Farmindustria (Chile)
and Segmenta (Brazil)
2017
Unprecedented method
of home
decontamination of
primary packaging
approved by Anvisa
2018
Acquisition of Stein's
portfolio in Central
America
2021
Partnership with Pfizer and
Biontech for the Covid-19
vaccine in Brazil
Registration of the first
international patent for an
innovative molecule
Portfolio acquisition from
Hypera in Colombia and
Mexico
2022
50 years anniversary
nossa historia tem
tem a sua marca
Grupo Eurofarma
50
anosView entire presentation